endocrinology

No shortage of insulins due to COVID-19: manufacturers

Insulin manufacturers have reassured people with diabetes that there are no supply problems due to the COVID-19 pandemic and there is no need to stockpile products. Despite the disruption to transport caused by pandemic measures and export bans imposed on insulin products by some countries, Australian pharmaceutical companies say they have sufficient quantities of insulin ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic